Jozy Altidore has agreed to put his name and face behind Advil’s new summer effort, a campaign that asks athletes to treat pain as a warning sign rather than a rite of passage. The brand, owned by Haleon, announced the “Rewriting Pain” push this week with Altidore listed as a campaign spokesperson as marketers try to reframe the old “no pain, no gain” mindset.
Natalie Halpern, a marketing executive on the campaign, framed the work in blunt terms: the aim is to “kind of flip the script, rewrite the story on what it means to have real strength.” Halpern pointed to soccer as an especially relevant stage — players commonly cover “between five and eight miles” in a single game — and said the mounting excitement around the 2026 World Cup made the summer the right moment to launch the message.
Advil backed the campaign with a survey of 1,000 U.S. adults who were current or former athletes, including people who had competed in collegiate, club or recreational sports. The findings the company highlighted are stark: 79% of those surveyed reported hearing phrases such as “push through the pain,” more than 80% said sports culture treats pain as a necessary part of success, and 86% said those kinds of phrases can put long-term health at risk.
Those numbers are the campaign’s weight — they are the reason Halpern says Advil wants to change language and behavior. “For all of us, pain is a signal. If we recognize it, treat it, and confront it, we’ll come back stronger,” she said. Halpern added that the company wants people to understand that “there’s no shame in stopping to treat it” and that “there's no badge of honor for pushing through.”
Advil positions the campaign as part of a broader effort to shift consumer thinking about pain and recovery. The company said it also tracks alternatives consumers use, from physical therapy to ice baths, and framed the effort as a push to normalize early treatment and reduce long-term harm. Advil, which is reportedly the best-selling pain reliever in the U.S., is owned by Haleon, which also owns Panadol and Voltaren.
The campaign’s request is simple and potentially awkward: stop when you feel pain. That instruction sits uneasily beside the reality that Advil’s business depends on widespread, recurring pain — the very condition the campaign asks athletes to prevent or treat promptly. The paradox is not hidden; it is the commercial context of a brand asking consumers to avoid or minimize the need for pain relief even as it markets products that treat pain.
How that paradox will be handled in creative is an open question. Advil has named Jozy Altidore as a spokesperson but has not specified how he will appear beyond that credit. The company plans to run the “Rewriting Pain” work through the summer across digital and social media platforms, timed to the heightened attention on soccer and the run-up to the 2026 World Cup.
The real test for the campaign will be whether its message — that “real strength is confronting pain and treating the inflammation,” as Halpern put it — changes locker-room language and on-field behavior, or whether it becomes another brand moment that coexists with the very habits it challenges. With Altidore attached and the World Cup atmosphere building, Advil will get a fast read this summer on whether athletes and everyday competitors embrace stopping as a form of strength, or simply note who to reach for when the game ends.
